20 results on '"Antiviral agents -- Product introduction"'
Search Results
2. Covid pill to be rolled out before Christmas; First home treatment offered to vulnerable as omicron forces return of pre-flight tests Anti-viral drugs are 'a new line of defence'
3. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products
4. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products
5. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products
6. Lactoferrin Market Size to Reach $395.75 million by 2030 - Latest Developments in Nutrition and Health Sector, New Product Launch, Expansion Plans and Future Outlook: The Brainy Insights
7. Lanxess Introduces Virkon S effective for African Swine Fever Biosecurity
8. Fitesa Launches Anti-Viral Product Line
9. United States : Trump EPA Approves First-Ever Long-Lasting Antiviral Product for Use Against COVID-19
10. TRUMP EPA APPROVES FIRST-EVER LONG-LASTING ANTIVIRAL PRODUCT FOR USE AGAINST COVID-19
11. 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19
12. 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19
13. New Novel Germicidal and Anti-Viral Products from Thin Air Energy(TM)
14. Lab-Validated Anti-Microbial Solution Now Available for All MetroClick|faytech NA Digital Signage, Kiosks and Touchscreen Hardware
15. AUM LifeTech and AUM BioTech Launch 'Knockdown Coronavirus'
16. Korean Firm HAAN Corporation Launches Breakthrough Antiviral Protection Globally
17. Korean Firm HAAN Corporation Launches Breakthrough Antiviral Protection Globally
18. New product information wording - Extracts from PRAC recommendations on signals Adopted at the 1-4 October 2018 PRAC
19. Fujifilm's role in Ebola fight captures hope in a snapshot
20. FDA approves addition of new warnings to hep C drug label
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.